Results 1 to 10 of about 69,003 (290)
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction
Summary: The CTLA-4 and PD-1 checkpoints control immune responses and are key targets in immunotherapy. Both pathways are connected via a cis interaction between CD80 and PD-L1, the ligands for CTLA-4 and PD-1, respectively. This cis interaction prevents
Maximillian A. Robinson +11 more
doaj +4 more sources
CD80 Costimulation Is Essential for the Induction of Airway Eosinophilia [PDF]
CD80 and CD86 (B7-1 and B7-2) are the ligands on antigen-presenting cells (APCs) which bind CD28 and deliver the costimulatory signals necessary for T cell activation. The reasons for the existence of two CD28 binding molecules are not well understood.
Harris, N. +5 more
openaire +5 more sources
Maximal ‘CD80-uria’ with minimal change [PDF]
Differentiation between minimal-change disease and focal segmental glomerulosclerosis remains challenging, particularly at early stages in children and adults. Garin et al. identify urinary CD80 excretion levels as a potential marker to differentiate the former entity from the latter. Thus, CD80 expression on podocytes, which was initially described in
Kistler, Andreas D., Reiser, Jochen
openaire +4 more sources
CD80 Is Upregulated in a Mouse Model with Shear Stress-Induced Atherosclerosis and Allows for Evaluating CD80-Targeting PET Tracers [PDF]
Molecular Imaging and Biology, 19 (1)
Meletta, Romana +11 more
openaire +7 more sources
It has been demonstrated that tumor cells express programed cell death protein 1 (PD-L1) to escape T lymphocytes that express programed cell protein 1 (PD-1), and PD-1/PD-L1 immune checkpoint inhibitors have been regarded in lung cancer patients. CD80 and CD86 are members of B7 superfamily which regulates T lymphocyte activation and tolerance. However,
Mitsunori Higuchi +2 more
exaly +4 more sources
Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors [PDF]
Introduction: Unresectable or recurrent thymic epithelial tumors (TETs) have a poor prognosis, and treatment options are limited. This study aimed to investigate the immunologic significance of CD80/CD86 or major histocompatibility complex class II (MHC ...
Hideki Ikeda, MD +12 more
doaj +2 more sources
In mammals, the binding of distinct costimulatory ligands CD80 and CD86 to their receptors is essential for optimal T cell activation. Previous studies have shown that only a single CD80/86 gene exists in rainbow trout (termed rtCD80/86A) and other ...
Yong-An Zhang +2 more
exaly +2 more sources
CD80/CD86 inhibitors are protein constructs which bind and inactivate CD80/CD86 on the surfaces of antigen-presenting B-cells and monocytes, blocking the costimulatory signal between these cells and CD28 on T-cells that is the second message of T-cell receptor/MHC interaction.
Pile, Kevin (R17082) +2 more
openaire +4 more sources
Differential Requirement for CD80 and CD80/CD86-Dependent Costimulation in the Lung Immune Response to an Influenza Virus Infection [PDF]
Abstract The CD28 costimulatory pathway is critical to T cell activation. Blockade of the interaction of CD28 with its ligands CD80 and CD86 using CTLA4-Ig has been proposed as a therapy for a number of immune-based disorders. We have used a murine model of influenza virus infection to study the role of CD28-dependent costimulation in
Lumsden, J. M. +4 more
openaire +6 more sources
Presence of CD80 and Absence of LAT in Modulating Cellular Infiltration and HSV-1 Latency
CD80 is the best-known costimulatory molecule for effective T cell functions. Many different reports have summarized the role of CD80 in HSV-1 and its functions in maintaining adaptive immunity, which is the main player in causing herpes stromal ...
Ujjaldeep Jaggi, Homayon Ghiasi
doaj +2 more sources

